Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Fahrbach

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Dermatology and Therapy|September 22, 2021
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-AnalysisKyle Fahrbach, Grammati Sarri, David M Phillippo, et al.
BMC Neurology|November 20, 2013
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysisKyle Fahrbach, Rachel Huelin, Amber L Martin, et al.
Respiratory Research|April 17, 2016
The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysisAmber L Martin, Jessica Marvel, Kyle Fahrbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 22, 2005
Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysisGraeme J Moyle, Karen Schoelles, Kyle Fahrbach, et al.
Infectious Diseases and Therapy|December 7, 2021
Meta-Regression of Herpes Zoster Incidence WorldwideDesmond Curran, Andrea Callegaro, Kyle Fahrbach, et al.
Future Oncology (London, England)|December 6, 2014
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysisSanjay Popat, Anders Mellemgaard, Kyle Fahrbach, et al.
Pharmacoeconomics|September 26, 2019
Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in JapanLuis Hernandez, Hiroyo Kuwabara, Anshul Shah, et al.
Seminars in Thrombosis and Hemostasis|February 23, 2024
Risk of Venous Thromboembolism by Cancer Type: A Network Meta-AnalysisMarissa B Betts, Xuejun Liu, Daniela R Junqueira, et al.
Clinical Rheumatology|June 23, 2021
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysisRupert W Jakes, Namhee Kwon, Beth Nordstrom, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyViolaine Planté-Bordeneuve, Hollis Lin, Jared Gollob, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Dermatology and Therapy|September 22, 2021
Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-AnalysisKyle Fahrbach, Grammati Sarri, David M Phillippo, et al.
BMC Neurology|November 20, 2013
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysisKyle Fahrbach, Rachel Huelin, Amber L Martin, et al.
Respiratory Research|April 17, 2016
The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysisAmber L Martin, Jessica Marvel, Kyle Fahrbach, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 22, 2005
Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysisGraeme J Moyle, Karen Schoelles, Kyle Fahrbach, et al.
Infectious Diseases and Therapy|December 7, 2021
Meta-Regression of Herpes Zoster Incidence WorldwideDesmond Curran, Andrea Callegaro, Kyle Fahrbach, et al.
Future Oncology (London, England)|December 6, 2014
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysisSanjay Popat, Anders Mellemgaard, Kyle Fahrbach, et al.
Pharmacoeconomics|September 26, 2019
Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in JapanLuis Hernandez, Hiroyo Kuwabara, Anshul Shah, et al.
Seminars in Thrombosis and Hemostasis|February 23, 2024
Risk of Venous Thromboembolism by Cancer Type: A Network Meta-AnalysisMarissa B Betts, Xuejun Liu, Daniela R Junqueira, et al.
Clinical Rheumatology|June 23, 2021
Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysisRupert W Jakes, Namhee Kwon, Beth Nordstrom, et al.
Expert Opinion on Pharmacotherapy|November 30, 2018
An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathyViolaine Planté-Bordeneuve, Hollis Lin, Jared Gollob, et al.
Pageof 6